Hagiwara A, Yukioka T, Ohta S, Tokunaga T, Ohta S, Matsuda H, Shimazaki S
Department of Traumatology and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.
AJR Am J Roentgenol. 1997 Oct;169(4):1151-6. doi: 10.2214/ajr.169.4.9308480.
We evaluated the efficacy of transcatheter arterial embolization (TAE) for patients with blunt hepatic injury.
Of 372 patients with trauma, 60 had evidence on CT of hepatic injury (Mirvis classification). Six of the 60 patients required emergency laparotomy and were excluded. Of the 54 remaining patients, 28 were classified as having high-grade hepatic injury (Mirvis classification of 3 or 4). All 28 underwent arteriography, and TAE was performed in single or multiple hepatic arterial branches when extravasation was seen. Angiography was repeated and cholescintigraphy was performed on patients with continued bleeding or biloma.
Injuries detected were grade 1 (n = 13), grade 2 (n = 13), grade 3 (n = 20), and grade 4 (n = 8). The injury was correlated with the degree of hemoperitoneum seen on CT. Patients with low-grade injuries (Mirvis classification of 1 or 2) were treated conservatively, and no deaths or liver-related morbidity occurred. Of the 28 patients with high-grade injury, 15 also had angiographic evidence of extravasation and underwent TAE. The average fluid resuscitation volume was significantly larger in this group than in the other 13 patients with high-grade injuries who did not undergo TAE. Embolization was successful in all 15 patients, and the shock index was significantly reduced after TAE. All patients survived, with follow-up at 1-8 months (2.5 +/- 1.8 months, mean +/- SD).
TAE is an effective alternative to surgery for patients with high-grade liver injury.
我们评估了经导管动脉栓塞术(TAE)对钝性肝损伤患者的疗效。
在372例创伤患者中,60例有肝脏损伤的CT证据(米尔维斯分类法)。60例患者中有6例需要急诊剖腹手术,被排除在外。在其余54例患者中,28例被分类为高级别肝损伤(米尔维斯分类为3级或4级)。所有28例均接受了血管造影,当发现造影剂外渗时,对单个或多个肝动脉分支进行了TAE。对持续出血或胆汁瘤患者重复进行血管造影并进行肝胆闪烁显像。
检测到的损伤为1级(n = 13)、2级(n = 13)、3级(n = 20)和4级(n = 8)。损伤程度与CT上所见的腹腔积血程度相关。低级别损伤(米尔维斯分类为1级或2级)的患者采用保守治疗,未发生死亡或与肝脏相关的并发症。在28例高级别损伤患者中,15例也有造影剂外渗的血管造影证据并接受了TAE。该组患者的平均液体复苏量明显大于其他13例未接受TAE的高级别损伤患者。15例患者栓塞均成功,TAE后休克指数明显降低。所有患者均存活,随访1 - 8个月(平均2.5±1.8个月,均值±标准差)。
对于高级别肝损伤患者,TAE是一种有效的手术替代方法。